Displaying 1 - 20 of 118 results
Released Company Title Industry Topic
17 Oct 2019
18:00 CEST
LYSOGENE Lysogene Appoints Mr. Stéphane Durant des Aulnois as Chief Financial Officer Biotechnology Journal / appointments
17 Oct 2019
18:00 CEST
LYSOGENE Lysogene annonce la nomination de Mr. Stéphane Durant des Aulnois en qualité de Directeur Administratif et Financier Biotechnology Journal / appointments
30 Sep 2019
18:00 CEST
LYSOGENE Lysogene publie ses résultats du premier semestre 2019 et fait le point sur ses activités Biotechnology Income
30 Sep 2019
18:00 CEST
LYSOGENE Lysogene Reports First Half 2019 Financial Results and Provides Operational Update Biotechnology Income
26 Sep 2019
18:00 CEST
LYSOGENE Lysogene annonce la nomination de Carole Deffez en qualité de nouvelle administratrice indépendante Biotechnology General meeting / Board Meeting
26 Sep 2019
18:00 CEST
LYSOGENE Lysogene Announces the Appointment of Carole Deffez as New Independent Board Director Biotechnology General meeting / Board Meeting
05 Sep 2019
18:00 CEST
LYSOGENE Lysogene : Un premier semestre 2019 crucial pour l’étude clinique de Phase 2-3 de Lysogene dans la MPS IIIA Biotechnology Products and services
05 Sep 2019
18:00 CEST
LYSOGENE Lysogene: A Pivotal Year 2019 for Lysogene’s MPS IIIA Phase 2-3 Clinical Trial Biotechnology Products and services
25 Jul 2019
18:00 CEST
LYSOGENE Lysogene Reports Second Quarter 2019 Financial Information Biotechnology Sales
25 Jul 2019
18:00 CEST
LYSOGENE LYSOGENE : Information financière du 2ème trimestre 2019 Biotechnology Sales
18 Jul 2019
18:00 CEST
LYSOGENE Lysogene annonce la création d’un Conseil Scientifique consultatif composé d'experts internationaux en thérapie génique du SNC Biotechnology Other subject
18 Jul 2019
18:00 CEST
LYSOGENE Lysogene Establishes Scientific Advisory Board with International Experts in CNS Gene Therapy Biotechnology Other subject
04 Jul 2019
18:00 CEST
LYSOGENE Lysogene : bilan semestriel du contrat de liquidité contracté avec la société de bourse gilbert dupont Biotechnology Other subject
11 Jun 2019
22:00 CEST
LYSOGENE Lysogene annonce le traitement du premier patient en Europe dans
l’essai clinique de phase II/III AAVance avec LYS-SAF302, traitement de
thérapie génique de la maladie de Sanfilippo de Type A (MPS IIIA)
Biotechnology Products and services
11 Jun 2019
22:00 CEST
LYSOGENE Lysogene Announces first European patient treated in AAVance, Phase
2/3 Clinical Trial Investigating LYS-SAF302, a Gene Therapy for the
Treatment of MPS IIIA (Sanfilippo Syndrome Type A)
Biotechnology Products and services
06 Jun 2019
18:00 CEST
LYSOGENE Lysogene Announces Workshop at National Institutes of Health (NIH) on
CNS Immunogenicity Considerations for AAV-Mediated Gene Therapy
Biotechnology Meetings / events
06 Jun 2019
18:00 CEST
LYSOGENE Lysogene annonce un workshop aux National Institutes of Health (NIH)
sur l’immunogénicité du SNC dans le cadre d’une thérapie génique
utilisant un vecteur AAV
Biotechnology Meetings / events
05 Jun 2019
18:00 CEST
LYSOGENE Lysogene: Annual Ordinary and Extraordinary General Meeting of 26
June 2019
Biotechnology General meeting / Board Meeting
05 Jun 2019
18:00 CEST
LYSOGENE LYSOGENE : Assemblée générale ordinaire annuelle et extraordinaire du
26 juin 2019
Biotechnology General meeting / Board Meeting
22 May 2019
18:00 CEST
LYSOGENE Lysogene Announces New Appointments to the Board of Directors Biotechnology General meeting / Board Meeting